Cargando…

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis(†)

Only around 80% of patients with generalized myasthenia gravis (MG) have serum antibodies to acetylcholine receptor [AChR; acetylcholine receptor antibody positive myasthenia gravis (AChR-MG)] by the radioimmunoprecipitation assay used worldwide. Antibodies to muscle specific kinase [MuSK; MuSK anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leite, Maria Isabel, Jacob, Saiju, Viegas, Stuart, Cossins, Judy, Clover, Linda, Morgan, B. Paul, Beeson, David, Willcox, Nick, Vincent, Angela
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442426/ https://www.ncbi.nlm.nih.gov/pubmed/18515870 http://dx.doi.org/10.1093/brain/awn092

Ejemplares similares

MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters
por: Koneczny, Inga, et al.
Publicado: (2013)

Novel Immunotherapies for Myasthenia Gravis
por: Nair, Sruthi S, et al.
Publicado: (2023)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016)

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018)

Role of complement in myasthenia gravis
por: San, Pyae Phyo, et al.
Publicado: (2023)

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys
por: Losen, Mario, et al.
Publicado: (2017)

Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018)

Complement deposition at the neuromuscular junction in seronegative myasthenia gravis
por: Hoffmann, Sarah, et al.
Publicado: (2020)

Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis
por: Vahabi, Zahra, et al.
Publicado: (2021)

Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
por: Vinciguerra, Claudia, et al.
Publicado: (2023)

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab
por: Vissing, John, et al.
Publicado: (2020)

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG
por: Huda, Saif, et al.
Publicado: (2017)

Myasthenia gravis: Antigen presentation by thymoma epithelial cells
por: Gilhus, N.E., et al.
Publicado: (1994)

Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report
por: Dan, Diana, et al.
Publicado: (2014)

Seronegative Myasthenia Gravis, as a Rare Autoimmune Condition in Turner Syndrome
por: Sharief, Rimah, et al.
Publicado: (2017)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
por: Lee, Sun Yong, et al.
Publicado: (2020)

Seronegative Ocular Myasthenia Gravis in an Older Woman With Transient Dizziness and Diplopia
por: Yoshioka, Naho, et al.
Publicado: (2022)

Congenital myasthenic syndrome in a cohort of patients with ‘double’ seronegative myasthenia gravis
por: Lorenzoni, Paulo José, et al.
Publicado: (2021)

A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis
por: Harris, Linda, et al.
Publicado: (2022)

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs
por: Cetin, Hakan, et al.
Publicado: (2020)

Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis
por: Vergoossen, Dana L. E., et al.
Publicado: (2021)

Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis
por: Fichtner, Miriam L., et al.
Publicado: (2020)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C
por: Amin, Saad Muhammad, et al.
Publicado: (2019)

Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma
por: Pandya, Shaunak K, et al.
Publicado: (2021)

Seronegative Myasthenia Gravis with Concomitant SARS-CoV-2 Infection in a Dog
por: Musteata, Mihai, et al.
Publicado: (2022)

The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis
por: Lee, Jung Jin, et al.
Publicado: (2014)

Seronegative antibody‐mediated neurology after immune checkpoint inhibitors
por: Wilson, Robert, et al.
Publicado: (2018)

Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis
por: Basile, Umberto, et al.
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Double-seronegative myasthenia gravis: case report
Publicado: (2022)

Case report: Coexistence of triple-seronegative myasthenia gravis and pathology-proven cryptogenic organizing pneumonia
por: Huang, Shi-Qi, et al.
Publicado: (2023)

Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies
Publicado: (1976)

Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development
por: Heldal, Anne Taraldsen, et al.
Publicado: (2014)

Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis
por: Neuhaus, Oliver, et al.
Publicado: (2019)

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis
por: Ayzenberg, Ilya, et al.
Publicado: (2019)

Heterogeneity of Acetylcholine Receptor Autoantibody–Mediated Complement Activity in Patients With Myasthenia Gravis
por: Obaid, Abeer H., et al.
Publicado: (2022)

High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravis
por: Wilf-Yarkoni, Adi, et al.
Publicado: (2020)

SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
por: Huda, Saif, et al.
Publicado: (2019)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qhd1tla5qiq99b21hpgk82hgv0